Security record · archived quarter
DGX
Quest Diagnostics Incorporated · Healthcare · Medical - Diagnostics & Research
15Tracked holders
—Δ holders
9.75MShares held
$1.33BReported value
+0New positions
−0Exits
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 154 | +1 | 78.04M | $16.53B | +7 | −6 |
| Q1 2026 | 156 | -1 | 76.50M | $14.98B | +4 | −6 |
| Q4 2025 | 156 | +4 | 87.42M | $15.15B | +5 | — |
| Q3 2025 | 16 | -1 | 54.97M | $10.47B | — | −2 |
| Q2 2025 | 15 | -3 | 44.54M | $8.00B | — | −3 |
| Q1 2025 | 15 | +2 | 17.80M | $3.01B | +3 | −1 |
| Q4 2024 | 13 | -2 | 18.37M | $2.77B | — | −2 |
| Q3 2024 | 14 | -1 | 12.70M | $1.97B | — | −1 |
| Q2 2024 | 15 | — | 9.75M | $1.33B | — | — |
Who holds it · Q2 2024
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passive) | 2.58M | — | $351.85M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 2.58M | — | $351.85M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Wellington Management ✦ | 2.55M | — | $349.15M | 0.1% | n/c | 1 | SEC ↗ |
| 4 | Wellington Management ✦ | 2.55M | — | $349.15M | 0.1% | n/c | 1 | SEC ↗ |
| 5 | Wellington Management ✦ | 2.55M | — | $349.15M | 0.1% | n/c | 1 | SEC ↗ |
| 6 | Wellington Management ✦ | 2.55M | — | $349.15M | 0.1% | n/c | 1 | SEC ↗ |
| 7 | Wellington Management ✦ | 2.55M | — | $349.15M | 0.1% | n/c | 1 | SEC ↗ |
| 8 | Wellington Management ✦ | 2.55M | — | $349.15M | 0.1% | n/c | 1 | SEC ↗ |
| 9 | Norges Bank ✦ (passive) | 1.29M | — | $176.32M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 1.17M | — | $159.76M | 0.2% | n/c | 1 | SEC ↗ |
| 11 | Citadel Advisors ✦ | 1.17M | — | $159.76M | 0.2% | n/c | 1 | SEC ↗ |
| 12 | Millennium Management ✦ | 948.63K | — | $129.85M | 0.1% | n/c | 1 | SEC ↗ |
| 13 | Point72 Asset Management ✦ | 299.74K | — | $41.03M | 0.1% | n/c | 1 | SEC ↗ |
| 14 | Marshall Wace ✦ | 189.03K | — | $25.87M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Marshall Wace ✦ | 189.03K | — | $25.87M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Adage Capital Partners ✦ | 160.41K | — | $21.96M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | T. Rowe Price ✦ | 155.25K | — | $21.25M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | T. Rowe Price ✦ | 155.25K | — | $21.25M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 147.47K | — | $20.19M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 147.47K | — | $20.19M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 147.47K | — | $20.19M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 147.47K | — | $20.19M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Bridgewater Associates ✦ | 143.72K | — | $19.67M | 0.1% | n/c | 1 | SEC ↗ |
| 24 | Renaissance Technologies ✦ | 84.10K | — | $11.51M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | Two Sigma Investments ✦ | 21.85K | — | $2.99M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | D. E. Shaw & Co. ✦ | 14.17K | — | $1.94M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | Gotham Asset Management ✦ | 6.75K | — | $923,256 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 1 holders, 41.40K shares, $8,113 reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q2 2024 ·
Methodology ·
Get this via the API